Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing
Organoid-based studies have revolutionized in vitro preclinical research and hold great promise for the cancer research field, including prostate cancer (PCa). However, experimental variability in organoid drug testing complicates reproducibility. For example, we observed PCa organoids to be less af...
Guardado en:
Autores principales: | Annelies Van Hemelryk, Lisanne Mout, Sigrun Erkens-Schulze, Pim J. French, Wytske M. van Weerden, Martin E. van Royen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/721bef334d5b4664922d111ed7466a0c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gastric Organoids: Progress and Remaining ChallengesSummary
por: Min-Jiao Pang, et al.
Publicado: (2022) -
Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway
por: Wang Y, et al.
Publicado: (2017) -
Retinal Organoids: Cultivation, Differentiation, and Transplantation
por: Xuying Li, et al.
Publicado: (2021) -
Corrigendum: Retinal Organoids: Cultivation, Differentiation, and Transplantation
por: Xuying Li, et al.
Publicado: (2021) -
Sweat Gland Organoids Originating from Reprogrammed Epidermal Keratinocytes Functionally Recapitulated Damaged Skin
por: Xiaoyan Sun, et al.
Publicado: (2021)